EIT Emerging Implant Technologies

EIT Emerging Implant Technologies is a medical device company specializing in the development and manufacturing of 3D-printed porous titanium implants for spinal surgery. The company's proprietary EIT Cellular Titanium technology creates scaffolds that mimic the structure of trabecular bone, promoting better osseointegration and biological fusion. Their product portfolio includes a range of cervical and lumbar cages designed to treat degenerative spinal conditions. In 2018, the company was acquired by DePuy Synthes, a part of the Johnson & Johnson Medical Devices Companies, to enhance their portfolio of interbody fusion devices. The integration of EIT's additive manufacturing expertise allows for the creation of implants with optimized porosity and stiffness, aiming to improve clinical outcomes for patients undergoing spinal fusion procedures.